NRXP

NRX Pharmaceuticals (NRXP)

About NRX Pharmaceuticals (NRXP)

NRX Pharmaceuticals, Inc. is a clinical-stage small molecule pharmaceutical company. It engages in developing of novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. The company was founded on September 18, 2017 and is headquartered in Wilmington, DE.

Details

Daily high
$1.40
Daily low
$1.35
Price at open
$1.35
52 Week High
$7.33
52 Week Low
$1.32
Market cap
14.7M
Dividend yield
0.00%
Volume
1
Avg. volume
71,206
P/E ratio
-.50

NRX Pharmaceuticals News

Details

Daily high
$1.40
Daily low
$1.35
Price at open
$1.35
52 Week High
$7.33
52 Week Low
$1.32
Market cap
14.7M
Dividend yield
0.00%
Volume
1
Avg. volume
71,206
P/E ratio
-.50